Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
February 28, 2026Kompass Autoimmun

Biomarker bei ANCA-assoziierter Vaskulitis: klinischer Nutzen, Fallstricke und ihre Rolle bei der Bewertung der Behandlungsergebnisse

View Full Paper
Ask AI
Bookmark
Share

Authors

CMChiara MarvisiCRCaterina RicordiCCCecilia Catellani

Discussion

Loading...

Member takes

Overview

This review discusses biomarkers related to disease activity in ANCA-associated vasculitis, indicating their clinical application and potential pitfalls.

Key Points

  • This work aims to identify reliable biomarkers for assessing disease activity and treatment response in ANCA-associated vasculitis.
  • Review of current and novel biomarkers in ANCA-associated vasculitis.
  • Discussion of serum, cell, and urine biomarkers.
  • Assessment of biomarkers for evaluating disease activity and treatment outcomes.
  • Identification of various biomarkers that help in profiling disease phenotypes.
  • Emphasis on the clinical applicability of biomarkers in treatment evaluation.
  • Highlighting novel detection methods for promising biomarkers.

Cite This Study

Marvisi et al. (2026) studied this question.

synapsesocial.com/papers/69a286850a974eb0d3c017f9https://doi.org/10.1159/000550561
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biomarkers in ANCA associated vasculitis: clinical utility, pitfalls and their role in the outcomes assessment2025 · 7 citations
  2. 2Investigating potential biomarkers associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis using Mendelian randomization and transcriptomic analysis2025 · 3 citations
  3. 3Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitides2026
  4. 4AB1274 PROSPECTIVE CELLULAR BIOMARKERS IN ANCA ASSOCIATED VASCULITIS: A PILOT STUDY2024
  5. 5Towards a proteomic plasma biomarker panel for diagnosing vasculitis remission2026